Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Fourth Chamber) of 27 February 2018 –  
Hansen Medical v EUIPO – Covidien (MAGELLAN)

(Case T-222/16)

(EU trade mark — Revocation proceedings — EU word mark MAGELLAN — Genuine use — Burden of proof — Article 15 and Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 18 and Article 58(1)(a) of Regulation (EU) 2017/1001) — Procedural irregularity committed by the Cancellation Division — Obligation to state reasons — Article 75 of Regulation No 207/2009 (now Article 94 of Regulation 2017/1001) — Oral proceedings — Article 77 of Regulation No 207/2009 (now Article 96 of Regulation 2017/1001))

| 1. | EU trade mark–Surrender, revocation and invalidity–Causes of revocation–Absence of genuine use of a trade mark–Proof of use of the earlier mark–Partial use–Effect–Concept of (part of the goods or services) covered by the registration  (Council Regulation No 207/2009, Arts 15 and 51(1)(a))  (see paras 25-28) |

| 2. | EU trade mark–Appeals procedure–Appeal brought against a decision by a department of EUIPO–Examination by the Board of Appeal–Scope  (Council Regulation No 207/2009, Art. 64(1))  (see para. 44) |

| 3. | EU trade mark–Procedural provisions–Statement of reasons for decisions–First sentence of Article 75 of Regulation No 207/2009–Scope identical to that of Article 296 TFEU  (Art. 296 TFEU; Council Regulation No 207/2009, Art. 75, first sentence)  (see paras 49, 50) |

| 4. | EU trade mark–Procedural provisions–Recourse to the oral procedure–Discretion of the Office  (Council Regulation No 207/2009, Art. 77(1))  (see para. 58) |

Re:

Action brought against the decision of the Second Board of Appeal of EUIPO of 3 February 2016 (Cases R 3092/2014-2 and R 3118/2014-2), relating to revocation proceedings between Hansen Medical and Covidien.

Operative part

The Court:

| 1. | Dismisses the action; |

| 2. | Orders Hansen Medical, Inc. to pay the costs. |

[Top](#document1)